Skipping pre-surgery blood pressure medicine for certain adrenal tumors
Part of Cancer clinical trials.
This trial studies whether it is safe to skip a specific pre-surgery blood pressure medicine (alpha-blocker) for people with normal blood pressure who have a pheochromocytoma or paraganglioma in one adrenal gland. It aims to see if fewer pre-op meds can still prevent risky blood pressure surges during surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 70 years old
- You are having one-side adrenal surgery (unilateral total adrenalectomy)
- Your tumor is causing pheochromocytoma/paraganglioma with “normal” blood pressure (not high) and certain lab levels are under 5× the lab’s upper limit
- You can give informed consent (and agree to study participation)
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special blood pressure monitoring system during surgery to remove a pheochromocytoma, a rare tumor that can cause dangerous blood pressure spikes. The system aims to help doctors keep your blood pressure stable during the operation.
This trial tests two targeted drugs, anlotinib and benmelstobart, for people with advanced pheochromocytoma or paraganglioma that has spread or come back after treatment. These drugs may help shrink tumors or slow their growth.
This study looks at heart and blood vessel problems that may happen after surgery to remove the adrenal gland (adrenalectomy) for pheochromocytoma or non-secreting tumors. It aims to understand how common these complications are so doctors can better care for patients like you.
This study looks at how different types of adrenal tumors might affect the heart during and after surgery. It aims to help doctors understand and reduce the risk of heart injury in patients having these tumors removed.
This study tests a minimally invasive procedure called superselective adrenal arterial embolization for people whose high blood pressure is hard to control with medications. The goal is to see if this treatment can safely lower blood pressure.
This trial tests whether noradrenaline is better than standard care for preventing dangerously low blood pressure during surgery. If you are having non-cardiac surgery that lasts at least an hour and are expected to stay overnight, this study may be for you.
Hear when a new Pheochromocytoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.